@cityofhope colleagues Honoring the retirement of Dr Kim Margolin- our incomparably talented, brilliant, rigorous, dedicated innovator of immunology-oncology. @montypal @DrRaviSalgia @SteveRosen14
Sarah Highlander PhD of TGen/COH and @montypal of COH (from his clinic!) Update on microbiome (bacteria & fungi)- science of impacts on DFS, OS with TKIs & IOs in Renal Ca, studies of impactable Rxs with more @ASCO 6/21. @cityofhope
Congratulations Dr Jennifer Piatt PhD as UUtah P&R Alumni of Year! Her pioneering work researching & teaching on unmet needs inc intimacy & sexuality for people with disabilities at @IndianaUniv started here. @drjenpiatt, @chericson, @drbethericson, @IUSPH
2
Great article by COH colleague and GU expert @YungLyou who cares for and is a COH go to expert who partners with treating oncologists to share the latest science to personalize care for GU patients. @COHMedOnc @DrRaviSalgia @montypal @TDorffOnc @ASCO
How to screen for targetable FGFR mutations from a community practice perspective fal.cn/3ePcs @YungLyou #ASCODailyNews #GUCSM
Dr Elizabeth Jaffee inspired 100’s of COHers today sharing cutting edge research & trials of IO+vac+other combos for personalized PM at Dr Caligiuri’s Presidential COH lectureship today. Future for even toughest cancers like Panc is improving step by step.
Fabulous article by Dan Hayes on Her2 development and our 3 pioneering colleagues who led the development into what is now helping so many women live longer or be cured of Her2+ breast cancer.
HER2 and Breast Cancer — A Phenomenal Success Story | NEJM nejm.org/doi/full/10.1056/NE…
Dr Parikh notes that the #ASCO #ConquerCancer foundation over the past 35 years funded early grants for 110 investigators chosen by peer review to present key new discoveries at this year’s #ASCO19!!
5














